delivery after pain. Z39.2
Conditions
Interventions
Intervention 1: Intervention in Case group is 500 mg Nigella Sativa capsule that give every 6 hours Till 24 hours with a Mefenamic Acid capsule that is routine treatment. Nigella Sativa capsuls made i
Treatment - Drugs
Placebo
Intervention in Case group is 500 mg Nigella Sativa capsule that give every 6 hours Till 24 hours with a Mefenamic Acid capsule that is routine treatment. Nigella Sativa capsuls made in Shahid Behesht
In The Control group Samples received Placebo capsules that are similar to Nigella Sativa capsules every 6 hours with Mefenamic Acid that is routin treatment .Placebo Capsuls made in Shahid Beheshti P
Sponsors
nursing and midwifery faculty of shahid beheshti medical science university
Eligibility
Sex/Gender
Female
Age
15 Years to 44 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria:1-Being Iranian.2-can read and write 3-Vaginal Delivery 4-Spontaneous Exit of Plasenta and Membranes 5-Multiparous 6-Gestational Age Between 37-42 Week 7-Be Complained of Moderate or Severe pain after Delivery8-No Instrumental Delivery or Pressure on Uterus 9-No 3 or 4 Degree Lacerration.10-No History of Cesarian Section or Pelvic Operation.11-Not used any Narcotic Drug during Labor and Delivery or used Atleast 4 hours ago.12-Not used Epidural or Spinal Anesthesia during Labor and Delivery.13-Mother Dosent have any Drug Addiction.14-Maternal History of Herbal Drugs Allergy.15-Feeding is Started ansd will be continued.16-Mother age between 15-44 years.17-Deliver a Singleton and Healthy Baby.18-No Maternal History of Chronic Disease Exclusion Criteria:1- Herbal Drug Sensitivity happen in Mother during study.2-Mother uses other Methods or Drugs to relive pain during study.3-Mother is Suffering serious complications after Delivery (such as High blood pressure, Severe bleeding after childbirth, Fever, etc.)4-Breastfeeding because of Mother or Baby causes, is disconnected.5--Mothers Dosent Tend to have continued Cooperation with the Researcher.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| After pain. Timepoint: befor intervention and 1 hour after it. Method of measurement: Mc gill pain ruler. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: after intervention. Method of measurement: side effect questionare. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactpadideh janati ataii
nursing and midwifery faculty of shahid beheshti medical science university
Outcome results
None listed